1.Ultrasound radiomics for distinguishing early and middle-late stage endometrial cancer
Xiaoli PENG ; Xueying WANG ; Lu ZHAO ; Shichun WANG ; Menglin LUO ; Lin REN ; Maochun ZHANG
Chinese Journal of Medical Imaging Technology 2024;40(11):1739-1744
Objective To observe the value of ultrasound radiomics for distinguishing early and middle-late stage endometrial cancer(EC).Methods A total of 294 women with EC were retrospectively enrolled,including 196 in early stage and 98 in middle-late stage.The patients were randomly divided into training set(n=206)and validation set(n=88)at the ratio of 7∶3.Clinical data were compared between different stages,and a clinical model was constructed.Radiomics features were extracted and screened based on ultrasound data,and radiomics models were constructed with logistic regression(LR),random forest(RF),support vector machine(SVM),Gaussian naive Bayes(GNB)and extreme gradient boosting(XGBoost),respectively.Finally,a clinical-radiomics model was constructed.The value of each model for distinguishing early and middle-late stages EC was observed.Results Significant differences of age of consultation,menstrual disorders,abdominal pain and proportion of menopause were found between patients with early and middle-late stage EC(all P<0.05).Among these 5 radiomics models,RF model had the highest area under the curve(AUC)for distinguishing early and middle-late stage EC.Pairwise comparison of clinical model,RF radiomics model and clinical-RF radiomics model showed that significant differences of AUC were found between each 2 models(all P<0.05),and clinical-RF radiomics model had the highest AUC.Conclusion Ultrasound radiomics based on RF were helpful for distinguishing early and middle-late stage EC,and better diagnostic efficacy could be obtained through combining with clinical data.
2.Efficacy and Safety of Atomization Inhalation of Polymyxin in the Adjunctive Treatment of Ventilator-associated Pneumonia:A Meta-analysis
Menglin LUO ; Xuan WANG ; Hao BAI ; Wanyi CHEN
China Pharmacy 2021;32(19):2400-2405
OBJECTIVE:To evaluate the efficacy and safety of atomization inhalation of polymyxin combined in the adjunctive treatment for ventilator-associated pneumonia ,and to provide evidence-based reference for clinical treatment. METHODS : Retrieved from Cochrane Library ,Embase,PubMed,Web of Science ,CNKI,CBM,VIP and Wanfang database (from their inception to March 2021),randomized controlled trials (RCTs)about efficacy and safety of atomization inhalation of polymyxin combined with conventional treatment (trial group ) versus conventional treatment (control group ) for ventilator- associated pneumonia were collected. After data extraction and quality evaluation of included literatures met inclusion and exclusion criteria , Meta-analysis was performed by using Rev Man 5.4 software. RESULTS :A total of 13 clinical studies were included ,involving 2 RCTs and 11 cohort studies with a total of 1 066 patients. The results of Meta-analysis showed that clinical response rate [OR = 1.53,95%CI(1.17,2.00),P=0.002],microbial clearance rate [OR =1.46,95%CI(1.11,1.91),P=0.007] of trial group were significantly higher than those of control group ,with statistical significance. There was no statistical significance in the mortality rate [OR =0.88,95%CI(0.68,1.14),P=0.32] and the incidence of renal impairment [OR =1.04,95%CI(0.72,1.49),P=0.85] between 2 groups. CONCLUSIONS :Based on current evidence ,atomization inhalation of polymyxin combined with conventional treatment can significantly improve clinical response rate and microbial clearance rate of patients with ventilator- associated pneumonia. However , more strictly-designed , long-term follow-up and large-scale RCTs are needed.
3.Efficacy and safety of continuous pump versus intermittent infusion of amphotericin B in the treatment of invasive fungal infection:a meta-analysis
Menglin LUO ; Rufu XU ; Xuelian HU ; Rong ZHANG
China Pharmacy 2023;34(9):1115-1118
OBJECTIVE To compare efficacy and safety of continuous pump versus intermittent infusion of amphotericin B in the treatment of invasive fungal infection, and to provide evidence-based reference for clinical treatment. METHODS Retrieved from PubMed, the Cochrane Library, Web of Science, Embase, Wanfang, CNKI, CBM and VIP database, randomized controlled trial (RCT) and cohort study about 24 h continuous pump (trial group) versus intermittent infusion (control group) of amphotericin B were collected from the inception to Jan. 2023. After literature screening and data extraction, the quality of RCT was evaluated with modified Jadad scale, and the quality of cohort study was evaluated with Newcastle-Ottawa scale. Meta-analysis and sensitivity analysis were performed by using RevMan 5.4 software. RESULTS A total of 7 literature were included, involving 1 RCT and 6 cohort studies with a total of 767 patients. The results of meta-analysis showed that the clinical effective rate [RR=1.44, 95%CI (1.13,1.83), P=0.003] of trial group was significantly higher than that of control group, and all-cause mortality rate [RR=0.37, 95%CI(0.19,0.72),P=0.003] and the incidence rate of infusion reaction [RR=0.28,95%CI(0.18,0.43), P<0.000 01] were significantly lower than control group; there was no statistical significance in the incidence rate of renal impairment between 2 groups [RR=0.71,95%CI(0.45,1.11),P=0.13] . The sensitivity analysis results showed that the results obtained in this study were robust. CONCLUSIONS The efficacy and safety of 24 h continuous pump of amphotericin B are better than those of intermittent infusion in the treatment of invasive fungal infection.
4.A sericin hydrogel scaffold for sustained dexamethasone release modulates macrophage polarization to promote mandibular bone defect repair in rats
Yiping FAN ; Menglin LUO ; Dongzong HUANG ; Lin LIU ; Bo FU ; Xiaoyu WANG ; Miaosheng GUAN ; Hongbo LI
Journal of Southern Medical University 2024;44(3):533-540
Objective To evaluate the efficacy of a modified sericin hydrogel scaffold loaded with dexamethasone(SMH-CD/DEX)scaffold for promoting bone defect healing by stimulating anti-inflammatory macrophage polarization.Methods The light-curable SMH-CD/DEX scaffold was prepared using dexamethasone-loaded NH2-β-cyclodextrin(NH2-β-CD)and sericin hydrogel and characterized by scanning electron microscopy(SEM),Fourier transform infrared spectroscopy(FTIR),biocompatibility assessment and drug release test.THP-1 macrophages incubated with the scaffold were examined for protein expressions of iNOS and Arg-1,mRNA expressions of IL-6,Il-10,Arg-1 and iNOS,and surface markers CD86 and CD206 using Western blotting,RT-qPCR,and flow cytometry.In a co-culture system of human periodontal ligament stem cells(HPDLSCs)and THP-1 macrophages,the osteogenic ability of the stem cells incubated with the scaffold was evaluated by detecting protein expressions of COL1A1 and Runx2 and expressions of ALP,Runx2,OCN and BMP2 mRNA,ALP staining,and alizarin red staining.In a rat model of mandibular bone defect,the osteogenic effect of the scaffold was assessed by observing bone regeneration using micro-CT and histopathological staining.Results In THP-1 macrophages,incubation with SMH-CD/DEX scaffold significantly enhanced protein expressions of Arg-1 and mRNA expressions of IL-10 and Arg-1 and lowered iNOS protein expression and IL-6 and iNOS mRNA expressions.In the co-culture system,SMH-CD/DEX effectively increased the protein expressions of COL1A1 and Runx2 and mRNA expressions of ALP and BMP2 in HPDLSCs and promoted their osteogenic differentiation.In the rat models,implantation of SMH-CD/DEX scaffold significantly promoted bone repair and bone regeneration in the bone defect.Conclusion The SMH-CD/DEX scaffold capable of sustained dexamethasone release promotes osteogenic differentiation of stem cells and bone defect repair in rats by regulating M2 polarization.
5.A sericin hydrogel scaffold for sustained dexamethasone release modulates macrophage polarization to promote mandibular bone defect repair in rats
Yiping FAN ; Menglin LUO ; Dongzong HUANG ; Lin LIU ; Bo FU ; Xiaoyu WANG ; Miaosheng GUAN ; Hongbo LI
Journal of Southern Medical University 2024;44(3):533-540
Objective To evaluate the efficacy of a modified sericin hydrogel scaffold loaded with dexamethasone(SMH-CD/DEX)scaffold for promoting bone defect healing by stimulating anti-inflammatory macrophage polarization.Methods The light-curable SMH-CD/DEX scaffold was prepared using dexamethasone-loaded NH2-β-cyclodextrin(NH2-β-CD)and sericin hydrogel and characterized by scanning electron microscopy(SEM),Fourier transform infrared spectroscopy(FTIR),biocompatibility assessment and drug release test.THP-1 macrophages incubated with the scaffold were examined for protein expressions of iNOS and Arg-1,mRNA expressions of IL-6,Il-10,Arg-1 and iNOS,and surface markers CD86 and CD206 using Western blotting,RT-qPCR,and flow cytometry.In a co-culture system of human periodontal ligament stem cells(HPDLSCs)and THP-1 macrophages,the osteogenic ability of the stem cells incubated with the scaffold was evaluated by detecting protein expressions of COL1A1 and Runx2 and expressions of ALP,Runx2,OCN and BMP2 mRNA,ALP staining,and alizarin red staining.In a rat model of mandibular bone defect,the osteogenic effect of the scaffold was assessed by observing bone regeneration using micro-CT and histopathological staining.Results In THP-1 macrophages,incubation with SMH-CD/DEX scaffold significantly enhanced protein expressions of Arg-1 and mRNA expressions of IL-10 and Arg-1 and lowered iNOS protein expression and IL-6 and iNOS mRNA expressions.In the co-culture system,SMH-CD/DEX effectively increased the protein expressions of COL1A1 and Runx2 and mRNA expressions of ALP and BMP2 in HPDLSCs and promoted their osteogenic differentiation.In the rat models,implantation of SMH-CD/DEX scaffold significantly promoted bone repair and bone regeneration in the bone defect.Conclusion The SMH-CD/DEX scaffold capable of sustained dexamethasone release promotes osteogenic differentiation of stem cells and bone defect repair in rats by regulating M2 polarization.
6.Fluid shear promotes apoptosis of glomerular endothelial cells by activation of Piezo 1
Menglin LUO ; Feng ZHENG ; Xinyao JI ; Caihong QI ; Yuheng XIAO ; Changchun NIU
Basic & Clinical Medicine 2024;44(9):1236-1242
Objective To investigate the effect of fluid shear(FS)on apoptosis of glomerular epithelial cells(GECs)and the role of Piezo 1 protein in it.Methods GECs(glomerular epithelial cells)of SD rat were cul-tured.Fluid shear stimulation was simulated by a Flexcell-T5000 tensiometer.Apoptosis level was detected by flow cytometry.The expression of Piezo 1 proteins in GECs was detected by immunofluorescence staining.The activating of Piezo 1 channels by fluid shear was observed using Ca2+indicator(Cal-590 AM).The effect of Piezo 1 on apop-tosis in GECs was analyzed after modulating the function or expression of Piezo 1 protein using the chemical activa-tor Yoda1,the inhibitor GsMtx 4 was regulated by lentivirus Lv-shPiezo 1.Results Compared with the blank controlgroup,apoptosis increased in the fluid shear group(P<0.05).The rate of apoptosis increased with the enhancing of fluid shear strength;Piezo 1 was commonly expressed in GECs.Fluid shear activated Piezo 1 chan-nel and enhanced expression of Piezo 1.The agonist Yoda1 promoted the apoptosis of GECs GsMtx 4 inhibited the apoptosis induced by fluid shear.Lv-shPiezo 1 knocked down the expression of Piezo 1 in GECs and the apoptosis rate of GECs in the knockdown group was reduced as compared to that in the control group and Lv-Ctrl group(P<0.05).Conclusions Fluid shear may promote apoptosis of GECs by activation of Piezo 1 and by enhancing expression of Piezo 1.
7.Meta-analysis of the adverse effects of drug-resistant tuberculosis drugs on pregnant women and fetuses
Shuyan QUAN ; Rufu XU ; Demei YING ; Menglin LUO ; Rong ZHANG
China Pharmacy 2022;33(4):497-502
OBJECTIVE To systematically evaluate the adverse effects of drug-resistant tuberculosis (DR-TB) drugs on pregnant women and fetuses ,so as to provide evidence-based reference for clinical medication. METHODS PubMed,Cochrane Library,Embase,CBM,CNKI,Wanfang database and VIP were searched by computer to collect randomized controlled trials (RCTs),cohort studies ,case-control studies ,case series and case reports about pregnant women exposed to DR-TB drugs. The retrieval time limit was from the establishment of each database to August 20,2021. After selecting the literature and extracting the data,the bias risk assessment tool recommended by 6.2 version of Cochrane system evaluator manual was used to evaluate the quality of the included RCTs ;Newcastle-Ottawa scale was used to evaluate the quality of the included cohort studies and case-control studies ;IHE scale issued by the Canadian Institute of Health Economics (IHE)was used to evaluate the quality of the included case series and case reports. RevMan 5.1 software was used for Meta-analysis of non-comparative binary data. RESULTS A total of 13 literature were included ,including 7 case series and 6 case reports ,involving 203 patients and 204 newborns;among them,there were 6 literature about non-comparative binary data. The results of meta-analysis showed that after exposure to DR-TB drugs,no newborn had birth defects ;the mortality of pregnant women was 0.09[95%CI(0.06,0.15),P<0.000 01];the neonatal mortality was 0.02[95%CI(0,0.06),P<0.000 01];the incidence of preterm birth was 0.14[95%CI(0.03,0.43),P=0.02];the incidence of infants with low birth weight was 0.17[95%CI(0.04,0.51),P=0.06];the incidence of growth retardation was 0.15[95%CI(0.09,0.22),P<0.000 01];the incidence of stillbirth was 0.05[95%CI(0.02,0.09),P<0.000 01];the incidence of abortion was 0.08[95%CI(0.05,0.14),P<0.000 01]. CONCLUSIONS Pregnant women exposed to DR-TB drugs can cause pregnant women ’s death and abortion ,neonatal death ,premature birth ,infants with low birth weight ,growth retardation and stillbirth,but there is no neonatal birth defect ;these adverse outcomes may be related to the history of DR-TB.
8.Urgent recommendation and practice of prevention and control of novel coronavirus disease 2019 (COVID-19) in intensive care units in West China Hospital of Sichuan University during the epidemics
WANG Lingying ; HE Lin ; DENG Lijing ; AN Qi ; ZHANG Jinmei ; ZHANG Fengming ; CHEN Lijun ; LUO Yulan ; FENG Mei ; LUO Bingru ; TANG Menglin
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2020;27(04):388-394
Objective To provide recommendations for the management of intensive care unit patients without novel coronavirus disease 2019 (COVID-19). Methods We set up a focus group urgently and identified five key clinical issues through discussion. Total 23 databases or websites including PubMed, National Guideline Clearing-House, Chinese Center for Disease Control and Prevention and so on were searched from construction of the library until February 28, 2020. After group discussion and collecting information, we used GRADE system to classify the evidence and give recommendations. Then we apply the recommendations to manage pediatric intensive care unit in the department of critical care medicine in our hospital. Results We searched 13 321 articles and finally identified 21 liteteratures. We discussed twice, and five recommendations were proposed: (1) Patients should wear medical surgical masks; (2) Family members are not allowed to visit the ward and video visitation are used; (3) It doesn’t need to increase the frequency of environmental disinfection; (4) We should provide proper health education about the disease to non-medical staff (workers, cleaners); (5) Medical staff do not need wear protective clothing. We used these recommendations in intensive care unit management for 35 days and there was no novel coronavirus infection in patients, medical staff or non-medical staff. Conclusion The use of evidence-based medicine for emergency recommendation is helpful for the scientific and efficient management of wards, and is also suitable for the management of general intensive care units in emergent public health events.